Search Results - "Gitter, B."

Refine Results
  1. 1

    Haspin inhibition delays cell cycle progression through interphase in cancer cells by Wang, Peiling, Hua, Xiangmei, Bryner, Yuge Han, Liu, Sijing, Gitter, Christopher B., Dai, Jun

    Published in Journal of cellular physiology (01-05-2020)
    “…Haspin (Haploid Germ Cell‐Specific Nuclear Protein Kinase) is a serine/threonine kinase pertinent to normal mitosis progression and mitotic phosphorylation of…”
    Get full text
    Journal Article
  2. 2

    Calcium phosphate nanoparticles as efficient carriers for photodynamic therapy against cells and bacteria by Schwiertz, J, Wiehe, A, Gräfe, S, Gitter, B, Epple, M

    Published in Biomaterials (01-07-2009)
    “…Abstract Calcium phosphate nanoparticles were surface-functionalized with different polymers, and photosensitizers were incorporated into this layer. The…”
    Get full text
    Journal Article
  3. 3

    Antimicrobial photodynamic active biomaterials for periodontal regeneration by Sigusch, B.W., Dietsch, S., Berg, A., Voelpel, A., Guellmar, A., Rabe, U., Schnabelrauch, M., Steen, D., Gitter, B., Albrecht, V., Watts, D.C., Kranz, S.

    Published in Dental materials (01-10-2018)
    “…Biomaterials for periodontal regeneration may have insufficient mechanical and antimicrobial properties or are difficult to apply under clinical conditions…”
    Get full text
    Journal Article
  4. 4

    Positively charged calcium phosphate/polymer nanoparticles for photodynamic therapy by Klesing, J., Wiehe, A., Gitter, B., Gräfe, S., Epple, M.

    “…The charge of nanoparticles influences their ability to pass through the cellular membrane, and a positive charge should be beneficial. The negative charge of…”
    Get full text
    Journal Article Conference Proceeding
  5. 5
  6. 6

    Induction of apoptosis in HaCaT cells by photodynamic therapy with chlorin e6 or pheophorbide a by Radestock, A, Elsner, P, Gitter, B, Hipler, U-C

    Published in Skin pharmacology and physiology (01-01-2007)
    “…The two photosensitizers, chlorin e6 and pheophorbide a, were tested in an in vitro model of topical photodynamic therapy (PDT). Both dyes accumulate in HaCaT…”
    Get more information
    Journal Article
  7. 7

    Amyloid β Peptide Potentiates Cytokine Secretion by Interleukin-1 β-Activated Human Astrocytoma Cells by Gitter, Bruce D., Cox, Laura M., Rydel, Russell E., May, Patrick C.

    “…Neurodegenerative processes in Alzheimer disease (AD) are thought to be driven in part by the deposition of amyloid β (Aβ), a 39- to 43-amino acid peptide…”
    Get full text
    Journal Article
  8. 8

    Reliability and longevity of implantable defibrillators by Hauser, Robert G., Casey, Susan A., Gitter, Christopher B., Tang, Chuen Y., Abdelhadi, Raed H., Gornick, Charles C., Stanberry, Larissa, Sengupta, Jay D.

    “…Purpose We hypothesized that data in manufacturers’ product performance reports (PPRs) can provide clinically valuable ICD and cardiac resynchronization…”
    Get full text
    Journal Article
  9. 9

    Study of the analgesic effect of lanepitant in patients with osteoarthritis pain by Goldstein, David J., Wang, Ouhong, Todd, Lora E., Gitter, Bruce D., DeBrota, David J., Iyengar, Smriti

    Published in Clinical pharmacology and therapeutics (01-04-2000)
    “…Objective Lanepitant selectively blocks substance P binding to the neurokinin‐1 receptor, preventing neurogenic inflammation and pain transmission. Substance P…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Evidence supporting a role for anti-Aβ antibodies in the treatment of Alzheimer’s disease by Morgan, Dave, Gitter, Bruce D

    Published in Neurobiology of aging (01-05-2004)
    “…Antibodies against Aβ have been suggested as potential therapeutic strategies for the treatment of Alzheimer disease (AD) for nearly 8 years. Animal studies…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist by Gitter, B D, Bruns, R F, Howbert, J J, Waters, D C, Threlkeld, P G, Cox, L M, Nixon, J A, Lobb, K L, Mason, N R, Stengel, P W

    “…LY303870 [(R)-1-[N-(2-methoxybenzyl)acetylamino]-3-(1H-indol-3-yl)-2-[N-(2-(4- (piperidin-1-yl)piperidin-1-yl)acetyl)amino]propane] is a new, potent and…”
    Get more information
    Journal Article
  13. 13

    Interleukin-6 secretion from human astrocytoma cells induced by substance P by Gitter, B D, Regoli, D, Howbert, J J, Glasebrook, A L, Waters, D C

    Published in Journal of neuroimmunology (01-04-1994)
    “…Functional NK-1 (substance P) receptors have been demonstrated previously on astrocytes from primary newborn rat brain cultures and human astrocytoma cells…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Regulation of Cytokine Secretion and Amyloid Precursor Protein Processing by Proinflammatory Amyloid Beta (Aβ) by GITTER, BRUCE D., BOGGS, LEONARD N., MAY, PATRICK C., CZILLI, DAN L., CARLSON, CHRISTOPHER D.

    Published in Annals of the New York Academy of Sciences (01-01-2000)
    “…: Neurodegenerative processes in Alzheimer's disease (AD) are thought to be driven, in part, by the deposition of amyloid beta (Aβ), a 39‐43‐aminoacid peptide…”
    Get full text
    Journal Article
  16. 16

    Influence of stringent and relaxed response on excretion of recombinant proteins and fatty acid composition in Escherichia coli by GITTER, B, DIEFENBACH, R, KEWELOH, H, RIESENBERG, D

    Published in Applied microbiology and biotechnology (01-04-1995)
    “…In contrast to stringent (relA+) cells of Escherichia coli, relaxed (relA) cells excreted recombinant proteins (beta-lactamase, interferon alpha 1) into the…”
    Get full text
    Journal Article
  17. 17

    Characteristics of human synovial fibroblast activation by IL-1β and TNFα by GITTER, B. D, LABUS, J. M, LEES, S. L, SCHEETZ, M. E

    Published in Immunology (01-02-1989)
    “…Human synovial fibroblast cell lines (HSN), established from tissues obtained from the knee joints of arthritis patients undergoing arthoplasty, were used to…”
    Get full text
    Journal Article
  18. 18

    [3H]LY303870, a novel nonpeptide radioligand for the NK-1 receptor by Gehlert, D R, Schober, D A, Hipskind, P A, Gitter, B D, Howbert, J J

    Published in Journal of neurochemistry (01-03-1996)
    “…We synthesized a potent and selective antagonist radioligand for the neurokinin (NK)-1 receptor and characterized its binding to guinea pig striatal membranes…”
    Get more information
    Journal Article
  19. 19

    Dose-response study of the analgesic effect of Lanepitant in patients with painful diabetic neuropathy by GOLDSTEIN, David J, OUHONG WANG, GITTER, Bruce D, IYENGAR, Smriti

    Published in Clinical neuropharmacology (01-01-2001)
    “…Lanepitant is effective in the formalin analgesic model suggesting efficacy in painful neuropathy. This study was designed to evaluate the dose-response effect…”
    Get full text
    Journal Article
  20. 20

    Use of non-peptide tachykinin receptor antagonists to substantiate the involvement of NK1 and NK2 receptors in a spinal nociceptive reflex in the rat by Picard, P, Boucher, S, Regoli, D, Gitter, B D, Howbert, J J, Couture, R

    Published in European journal of pharmacology (02-03-1993)
    “…Non-peptide antagonists of the NK1 and NK2 receptors were tested as inhibitors of the reaction time in the rat tail-flick and on the decrease of reaction time…”
    Get more information
    Journal Article